Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur-MSD (SPM) (Mfr # DK-1577272925-2016009185) on 15-SEP-2016. Case received from a physician via HA on 12-SEP-2016 under reference numbers DK-DKMA-ADR 23635681 / DK-DKMA-WBS-0004426. A 14-year-old female adolescent patient received GARDASIL (batch number Not available, Dosed 1) via intramuscular route on 20-JAN-2010, GARDASIL (batch number, Not available, Dose 2) via intramuscular route on 24-MAR-2010, GARDASIL, (batch number Not available, Dose 3) via intramuscular route on 03-NOV-2010. The patient experienced Abdominal pain, Migraine headache, Tension headaches, Syncope, Near syncope, Dizziness, Palpitation, Nausea, Diarrhea, Lactose tolerance test abnormal, Voiding difficulty, Hyperventilation, Shortness of breath, Fatigue, Dry mouth, sleeping disorder, memory difficulty, frequent colds, Pneumonia, Hot flashes, Sweating abnormal, worsening of joint pain, Difficulty focusing eyes and Tiredness on an unknown date. The patient reported that her first symptom started 4-6 months after 2nd vaccine dose in the form of abdominal pain and diarrhea. Then the other reported symptoms followed. Before vaccinations the patient ran / strength-trained about one and half to 2 hours daily. Still exercises around 4 times per week, but her body feels more tired. Patient has been absent many times from studies due to migraines and fatigue. Patient has started assistant training and also works in the weekends. She always goes home with a headache after work and school and often takes a nap after school or work due to tiredness. Does not have the energy to meet with friends due to tiredness. Other vaccines: No. other medicines: Unknown. The patient''s outcome was reported as Not Recovered/Not Resolved.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166